학술논문

Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis
Document Type
Clinical report
Source
Breast Cancer Research and Treatment. July, 2022, Vol. 194 Issue 1, p13, 11 p.
Subject
Medical research -- Analysis -- Physiological aspects
Medicine, Experimental -- Analysis -- Physiological aspects
Immunohistochemistry -- Physiological aspects -- Analysis -- Research
Cancer patients -- Prognosis
Metastasis -- Prognosis -- Development and progression -- Research
Immune response -- Research -- Physiological aspects -- Analysis
Pertuzumab -- Research
Breast cancer -- Prognosis -- Development and progression -- Research
Language
English
ISSN
0167-6806
Abstract
Purpose Hypoxia-Inducible Factor HIF1[alpha] and lactate dehydrogenase LDHA drive anaerobic tumor metabolism and define clinical aggressiveness. We investigated their expression in breast cancer and their role in immune response and prognosis of breast cancer. Methods Tissue material from 175 breast cancer patients treated in a prospective study were analyzed with immunohistochemistry for HIF1[alpha] and LDH5 expression, in parallel with the tumor-infiltrating lymphocyte TIL-density and tertiary lymphoid structure TLS-density. Results High LDH5 expression was noted in 48/175 tumors, and this was related to HIF1[alpha] overexpression (p < 0.0001), triple-negative TNBC histology (p = 0.01), poor disease-specific survival (p < 0.007), metastasis (p < 0.01), and locoregional recurrence (p = 0.03). High HIF1[alpha] expression, noted in 39/175 cases, was linked with low steroid receptor expression (p < 0.05), her2 overexpression (p = 0.01), poor survival (p < 0.04), and high metastasis rates (p < 0.004). High TIL-density in the invading tumor front (TILinv) was linked with low LDH5 and HIF expression (p < 0.0001) and better prognosis (p < 0.02). High TIL-density in inner tumor areas (TILinn) was significantly linked with TNBC. Multivariate analysis showed that PgR-status (p = 0.003, HR 2.99, 95% CI 1.4-6.0), TILinv (p = 0.02, HR 2.31, 95% CI 1.1-4.8), LDH5 (p = 0.01, HR 2.43, 95% CI 1.2-5.0), N-stage (p = 0.04, HR 2.42, 95% CI 1.0-5.8), T-stage (p = 0.04, HR 2.31, 95% CI 1.0-5.1), and her2 status (p = 0.05, HR 2.01, 95% CI 1.0-4.2) were independent variables defining death events. Conclusion Overexpression of LDH5, an event directly related to HIF1[alpha] overexpression, characterizes a third of breast tumors, which is more frequent in TNBC. Both HIF1[alpha] and LDH5 define cold breast cancer microenvironment and poor prognosis. A rational is provided to study further whether metabolic manipulations targeting HIF and LDH5 may enhance the antitumor immune response in breast cancer.
Author(s): Alexandra Giatromanolaki [sup.1], Anastasia G. Gkegka [sup.1], Stamatia Pouliliou [sup.2], Eirini Biziota [sup.3], Stylianos Kakolyris [sup.3], Michael Koukourakis [sup.2] Author Affiliations: (1) grid.12284.3d, 0000 0001 2170 8022, Department of [...]